Outcome analysis of pediatric hemophagocytic lymphohistiocytosis

被引:20
|
作者
Chen, Tsung-Yen [1 ,2 ]
Hsu, Mei-Hsin [1 ,3 ]
Kuo, Hsuan-Chang [1 ,4 ,5 ]
Sheen, Jiunn-Ming [6 ]
Cheng, Ming-Chou [1 ]
Lin, Ying-Jui [1 ,4 ]
机构
[1] Chang Gung Univ, Coll Med, Div Crit Care, Dept Pediat,Kaohsiung Chang Gung Mem Hosp, 123 Tapei Rd, Kaohsiung 333, Taiwan
[2] I Shou Univ, Dept Pediat, E Da Hosp, Kaohsiung, Taiwan
[3] Chang Gung Univ, Coll Med, Div Neurol, Dept Pediat,Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan
[4] Chang Gung Univ, Coll Med, Div Cardiol, Dept Pediat,Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan
[5] Meiho Univ, Dept Nursing, Neipu Township, Taiwan
[6] Chang Gung Univ, Coll Med, Div Hematol, Dept Pediat,Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan
关键词
Pediatric hemophagocytic syndrome; Hemophagocytic lympho histiocytosis; Macrophage activation syndrome; Mortality; Intensive care unit;
D O I
10.1016/j.jfma.2020.03.025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening disease associated with rapid clinical deterioration and the need for intensive care; therefore, it is essential to identify clinical parameters related to mortality and establish prognostic factors correlated with unfavorable outcome in high risk patients whose treatment may fail. Methods: Between January 2004 and December 2018, a total of 51 pediatric patients (less than 18 years old) who fulfilled the diagnostic criteria of HLH-2004 with documented results of bone marrow investigations at Kaohsiung Chang Gung Memorial Hospital were enrolled. The treatment protocol was based on hemophagocytic lymphohistiocytosis-94 (HLH-94) and HLH-2004. We retrospectively reviewed electronic medical records (EMR) including clinical features, length of intensive care unit (ICU) stay, serological tests, microscopic reports of bone marrow examination, and ultrasound examination reports at diagnosis to identify prognostic factors. The patients were divided into four groups based on etiology; these included infection associated hemophagocytic syndrome (IAHS), macrophage activation syndrome (MAS), malignancy associated hemophagocytic lymphohistiocytosis (MA-HLH), and idiopathic hemophagocytic lymphohistiocytosis (IHLH) to identify differences among the groups. Results: Out of 51 patients enrolled, 27 patients had IAHS, 12 MAS, 8 MA-HLH, and 4 IHLH. The median age at diagnosis was 7 years. The overall mortality rate was 15.7% (there was no mortality in the MA-HLH group); the mean length of ICU stay was 6 +/- 20.8 days. Longer activated partial thromboplastin time (aPTT) (p = 0.007), lower sodium concentration (p = 0.0007), and higher creatinine (p = 0.032) and aspartate aminotransferase (AST) (p = 0.017) were significantly related to mortality. Multivariate Cox regression analysis demonstrated that aPTT (p = 0.045, HR = 1.03, 95% CI = 1.0-1.1) was an independent risk factor for mortality. The receiver operating characteristic (ROC) curve showed that aPTT longer than 44.35 s was the cutoff value predicting mortality, with a sensitivity and specificity of 72% and 66.7%, respectively. Conclusion: MA-HLH had the lowest mortality rate, as most children died from the underlying malignant disease and not from HLH. Impaired liver and renal functions were related to mortality. Prolonged aPTT > 44.35 s is a strong predictive factor for mortality. Copyright (C) 2020, Formosan Medical Association. Published by Elsevier Taiwan LLC.
引用
收藏
页码:172 / 179
页数:8
相关论文
共 50 条
  • [31] Secondary Hemophagocytic Lymphohistiocytosis: Think of the Devil Lurking!
    Pannu, Ashok K.
    Bhalla, Ashish
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2022, 26 (05) : 543 - 544
  • [32] Hemophagocytic lymphohistiocytosis: Analysis of 18 cases
    Hernandez-Jimenez, Pilar
    Diaz-Pedroche, Carmen
    Laureiro, Jaime
    Madrid, Olaya
    Martin, Estela
    Lumbreras, Carlos
    MEDICINA CLINICA, 2016, 147 (11): : 495 - 498
  • [33] Hemophagocytic lymphohistiocytosis
    Michot, J. -M.
    Hie, M.
    Galicier, L.
    Lambotte, O.
    Michel, M.
    Bloch-Queyrat, C.
    Hermine, O.
    REVUE DE MEDECINE INTERNE, 2013, 34 (02): : 85 - 93
  • [34] Hemophagocytic lymphohistiocytosis: an update for nephrologists
    Filippone, Edward J.
    Farber, John L.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2016, 48 (08) : 1291 - 1304
  • [35] Necrotizing epiglottitis and hemophagocytic lymphohistiocytosis
    Kong, Michael S.
    Engel, Samuel H.
    Zalzal, George H.
    Preciado, Diego
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2009, 73 (01) : 119 - 125
  • [36] Hemophagocytic Lymphohistiocytosis
    Henter, Jan-Inge
    NEW ENGLAND JOURNAL OF MEDICINE, 2025, 392 (06) : 584 - 598
  • [37] Hemophagocytic Lymphohistiocytosis
    Ponnatt, Tanya Sajan
    Lilley, Cullen M.
    Mirza, Kamran M.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2022, 146 (04) : 507 - 519
  • [38] Hemophagocytic Lymphohistiocytosis
    Kacer, Ayse Gonca
    Celkan, Tiraje Tulin
    BALKAN MEDICAL JOURNAL, 2022, 39 (05) : 309 - 317
  • [39] COMPARISON OF CLINICAL FEATURES AND PROGNOSTIC CORRELATION ANALYSIS OF PEDIATRIC HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS COMPLICATED WITH SEPSIS
    Xiaomei, Z.
    Ying, W.
    PEDIATRIC CRITICAL CARE MEDICINE, 2022, 23 (11)
  • [40] Hemophagocytic lymphohistiocytosis
    Papadakis, V.
    ARCHIVES OF HELLENIC MEDICINE, 2011, 28 (02): : 175 - 181